Article
Noradrenergic signaling controls Alzheimer's disease pathology via activation of microglial β2 adrenergic receptors
2024-02-26
Abstract excerpt
<title>Abstract</title> <p>Norepinephrine (NE) is a potent anti-inflammatory agent in the brain. In Alzheimer’s disease (AD), the loss of NE signaling heightens neuroinflammation and exacerbates amyloid pathology. NE inhibits surveillance activity of microglia, the brain’s resident immune cells, via their β2 adrenergic receptors (β2ARs). Here, we investigate the role of microglial β2AR signaling in AD pathology i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 976e0e56-4cc9-500a-b055-2615fe36781f
- DOI
- 10.21203/rs.3.rs-3976896/v1
